At a glance
- ÐÇ¿ÕÓéÀÖ¹ÙÍø prioritizes cost-effective, scalable interventions, policies, and research to reduce the incidence of HIV, viral hepatitis, STIs, and Tuberculosis.
- ÐÇ¿ÕÓéÀÖ¹ÙÍø investments fund state, local and territorial health departments, community-based organizations, national organizations, academic institutions, and education agencies.
- These prevention and treatment programs are essential to the nation’s public health infrastructure.
Funding overview
ÐÇ¿ÕÓéÀÖ¹ÙÍø’s HIV, viral hepatitis, STI, and TB programs fund state, tribal, local and territorial health departments to implement high-impact prevention programs, address infectious diseases and reduce disparities. ÐÇ¿ÕÓéÀÖ¹ÙÍø provides financial assistance and assigns federal employees with on-the-ground experience to state, tribal, local and territorial health departments to reduce HIV, viral hepatitis, STI, and tuberculosis infections, link those who test positive to care and treatment, and prevent death. Upon request, ÐÇ¿ÕÓéÀÖ¹ÙÍø can provide direct assistance, which may include deploying ÐÇ¿ÕÓéÀÖ¹ÙÍø public health advisors or epidemiologists to assist with disease investigations.
ÐÇ¿ÕÓéÀÖ¹ÙÍø funding and training support field staff, including Disease Intervention Specialists (DIS). DIS are frontline public health staff who help identify individuals who may not know they were exposed to STIs, HIV, and tuberculosis (TB). These specially trained staff then connect patients to testing and treatment. DIS are also a critical piece of the public health infrastructure when emergencies and public health threats emerge, protecting Americans from a wide variety of outbreaks and epidemics, including HIV, tuberculosis, Ebola, influenza, Zika, COVID-19, and mpox.
ÐÇ¿ÕÓéÀÖ¹ÙÍø supports local efforts, such as outbreak response teams, and training for health care providers, as well as community/partnership engagements. ÐÇ¿ÕÓéÀÖ¹ÙÍø provides technical assistance to all states on preventing and responding to HIV, STIs, TB, and viral hepatitis outbreaks, and deploys epidemiologists, laboratorians, public health advisors, and disease intervention specialists, to provide on-the-ground support for outbreak response in states where support is requested. ÐÇ¿ÕÓéÀÖ¹ÙÍø has made significant investments in programs that focus on surveillance, screening recommendations, epidemiologic studies, and disease intervention specialists.
In addition, ÐÇ¿ÕÓéÀÖ¹ÙÍø funds community-based and national organizations to complement health departments’ prevention efforts. Funded community-based and national organizations foster collaborations with providers and clients to provide effective prevention programs and services and inform guidelines and policies. Facilitating strong collaborations between communities and clinical services will reduce disparities, enhance the effectiveness of partnerships, and improve prevention activities.
How is ÐÇ¿ÕÓéÀÖ¹ÙÍø funding used for HIV, viral hepatitis, STIs, tuberculosis prevention?
In FY 2023, the U.S. Congress enacted a spending bill that appropriated $1,391,056,000 to ÐÇ¿ÕÓéÀÖ¹ÙÍø to prevent and control HIV, viral hepatitis, STIs, tuberculosis, infectious diseases and the opioid epidemic, and to promote adolescent and school health. The FY 2023 operating budget1 amount was $1,281,310,018:
- Approximately 76% of the operating budget was awarded through extramural mechanisms. The majority of this funding is awarded to state, tribal, local, and territorial health departments, community-based organizations, national organizations, academic institutions, and education agencies as grants and cooperative agreements.
- Approximately 24% of the operating budget was spent on internal ÐÇ¿ÕÓéÀÖ¹ÙÍø resources that enable the nation's response to infectious disease, including world-class laboratories, outbreak response, cutting-edge research, and technical assistance to health departments and community-based organizations.
These expenditures achieved measurable reduction in risk factors, illness, and death in communities at all levels of social status.
Priorities
ÐÇ¿ÕÓéÀÖ¹ÙÍø uses a comprehensive approach to stop the spread of infectious diseases among people who use drugs. The nation’s public health crisis involving drug use of opioids and other drugs, including methamphetamines and cocaine, is fueling increases in infectious diseases, such as viral hepatitis and HIV.
HIV, viral hepatitis, STI, and tuberculosis laboratory services at ÐÇ¿ÕÓéÀÖ¹ÙÍø work around the clock to protect the health of all Americans. These laboratories use vital discoveries and cutting-edge technology, some of which are only available at ÐÇ¿ÕÓéÀÖ¹ÙÍø laboratories.
- Operating budget: Amount of funding obligated by an organization during the fiscal year to meet both routine business costs and program needs.